Live Biotherapeutic Products & Microbiome CDMO Market Set to Hit USD 1.44 Billion by 2036, Growing at 30.1% CAGR
The global live biotherapeutic products and microbiome contract development and manufacturing organization (CDMO) market is estimated at USD 104.0 million in 2026 and is projected to reach USD 1.44 billion by 2036, expanding at a compound annual growth rate (CAGR) of 30.1%, according to Fact.MR. The market is expected to create an absolute dollar opportunity of approximately USD 1.3 billion...
0 Σχόλια 0 Μοιράστηκε 3 Views 0 Προεπισκόπηση